A new and hopefully potent ADC. Antibody-drug conjugates, not only for prostate cancer, are a hot topic now, so they should get better and better as competition rises.
biospace.com/angiex-announc...
note: TM4SF1 is expressed by prostate cancer as well
Hi Prof Attard said not recruiting until next year
PARP inhibitor Olaparib, phase 3 study findings (PROpel)Don't take it as medical advice: training routine
MRI prior to HDR Brachy and HDR intensity.
PSA holding low!!General health (also not bad for PC): a fasting-mimicking diet reduce insulin resistance, liver fat, immune system aging, and biological age
